Atabak Mokari
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $18.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 4,20091,930 held (−4%) | $105.54 | $443K | +14.8% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 8,95682,974 held (−10%) | $106.96 | $958K | +13.3% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 40082,574 held (−0%) | $108.46 | $43K | +11.7% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 2,20280,372 held (−3%) | $110.03 | $242K | +10.1% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 60079,772 held (−1%) | $110.95 | $67K | +9.2% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 4,70075,072 held (−6%) | $113.18 | $532K | +7.1% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 15,47759,595 held (−21%) | $114.96 | $1.8M | +5.4% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 14,22245,373 held (−24%) | $115.87 | $1.6M | +4.6% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 7,08938,284 held (−16%) | $116.96 | $829K | +3.6% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 8,26730,017 held (−22%) | $117.93 | $975K | +2.8% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 4,78325,234 held (−16%) | $118.73 | $568K | +2.1% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 8,10317,131 held (−32%) | $119.95 | $972K | +1.0% |
| Aug 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 1,00116,130 held (−6%) | $120.67 | $121K | +0.4% |
| Jul 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 7,91948,211 held (−14%) | $86.78 | $687K | +39.7% |
| Jul 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 28,46019,751 held (−59%) | $87.89 | $2.5M | +37.9% |
| Jul 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 3,52016,231 held (−18%) | $88.30 | $311K | +37.2% |
| Jul 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 10116,130 held (−1%) | $89.43 | $9K | +35.5% |
| Jun 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 9,43446,696 held (−17%) | $80.02 | $755K | +51.4% |
| Jun 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 11,08135,615 held (−24%) | $80.94 | $897K | +49.7% |
| Jun 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 19,48316,132 held (−55%) | $81.81 | $1.6M | +48.1% |
| Jun 17SEC | CORTCorcept Therapeutics Inc | Sell Plan | 216,130 held (−0%) | $82.45 | $165 | +47.0% |
| Jun 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 40,00015,257 held (−72%) | $70.00 | $2.8M | +73.1% |
- Sell
CFO Atabak Mokari sold $443K of CORT at $105.54 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Atabak Mokari sold $958K of CORT at $106.96 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Atabak Mokari sold $43K of CORT at $108.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Atabak Mokari sold $242K of CORT at $110.03 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Atabak Mokari sold $67K of CORT at $110.95 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Atabak Mokari sold $532K of CORT at $113.18 — pre-scheduled 10b5-1 plan sale.